Indications for use:
- Treatment of respiratory infections caused by strains of Pasteurella multocida, Mannheimia haemolytica, Mycoplasma bovis and Histophilus somni susceptible to marbofloxacin.
- Treatment of acute mastitis caused by strains of Escherichia coli susceptible to marbofloxacin during the lactation period.
- Treatment of Postpartum Dysgalactia Syndrome – (PDS) – (Metritis Mastitis Agalactia Syndrome) caused by bacterial strains susceptible to marbofloxacin.
Marketing authorisation holder: VET-AGRO Multi-Trade Company Sp. z o.o., Gliniana 32, 20-616 Lublin, Poland